Login
$LIVN
$81.25 +$0.59 (0.73%) Close

$LIVN 3 SEC Filings

Filed On Filing
02 Sep 2026 Form 3: Liddy Anne M., Chief Legal Officer

No securities owned

05 Aug 2026 Form 3: Folli Stefano, President, Cardiopulmonary
11 Jun 2026 Form 3: Nygaard-Andersen Jette, Director

Holds 0 shares of Common Stock

04 Sep 2025 Form 3: Zurbay Donald, Director

Holds 0 shares of Ordinary Shares

17 Jan 2025 Form 3: Kozmina Natalia, Chief Human Resources Officer

Holds 0 shares of Ordinary Shares

15 Oct 2024 Form 3: Podlogar Susan M, Director

Holds 0 shares of Ordinary Shares

09 Aug 2024 Form 3: Poletti Franco, President, Cardiopulmonary

Holds 6,667 shares of Ordinary Shares

17 May 2024 Form 3: Tezel Ahmet, Chief Innovation Officer

Holds 0 shares of Ordinary Shares

11 Mar 2024 Form 3: Bolton Stephanie, President, Global Epilepsy

Holds 5,461 shares of Ordinary Shares

04 Mar 2024 Form 3: Makatsaria Vladimir, Director

Holds 0 shares of Ordinary Shares

13 Oct 2023 Form 3: Barry James Christopher, Director

Holds 0 shares of Ordinary Shares

25 Nov 2022 Form 3: Hutchinson Michael Damon, Chief Legal Officer

Holds 0 shares of Ordinary Shares

19 Sep 2022 Form 3: Story Brooke, Director

Holds 0 shares of Ordinary Shares

17 Jun 2022 Form 3: Wilver Peter M, Director

Holds 0 shares of Ordinary Shares

08 Dec 2020 Form 3: Schermerhorn Todd C, Director

Holds 0 shares of Ordinary Shares

06 Nov 2020 Form 3: Shvartsburg Alex, Interim CFO

Holds 1,537 shares of Ordinary Shares

10 Jan 2020 Form 3: Dolci Marco, SVP Global Operations, R&D

Holds 614 shares of Ordinary Shares

10 Jan 2020 Form 3: Khoury Roy, President, International

Holds 1,129 shares of Ordinary Shares

20 Jun 2019 Form 3: Enxing Seng Stacy, Director

Holds 0 shares of Ordinary Shares

26 Apr 2019 Form 3: Hebbelinck Trui, Chief Human Resources Officer

Holds 0 shares of Ordinary Shares

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support